ANGELINA COLLINS: Open Payments
NPI 1720001324 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$113,017 in 130 payments from 7 companies in 2025. Trend: 2023 $54,875 · 2024 $85,904 · 2025 $113,017
Speaker / faculty: $87,012Consulting: $15,815Travel & lodging: $7,298Food & beverage: $2,892
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 62 | $67,440 |
| ABBVIE INC. | 46 | $30,196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $9,504 |
| Janssen Scientific Affairs, LLC | 4 | $4,766 |
| Celltrion USA Inc. | 1 | $955 |
| Inspire Medical Systems, Inc. | 1 | $85 |
| Lilly USA, LLC | 1 | $73 |
Products named: TREMFYA, SKYRIZI, ENTYVIO, RINVOQ, STELARA, INSPIRE, OMVOH.
Industry payments across CA — which companies pay providers there.
